Impact of malaria on HIV infection;Impact du paludisme sur l'infection par le VIH

Medecine et Maladies Infectieuses

Volumn 40, Issue 5, 2010, Pages 256-267

  Martin Blondel, G ^a   Soumah, M ^a   Camara, B ^a   Chabrol, A ^a   Porte, L ^a   Delobel, P ^a   Cuzin, L ^a   Berry, A ^b   Massip, P ^a   Marchou, B ^a  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

HIV; Malaria; Viral load

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; ARTEMISININ; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; COTRIMOXAZOLE; CYTOCHROME P450; CYTOCHROME P450 3A4; DAPSONE; EFAVIRENZ; FANSIDAR; HALOFANTRINE; MEFLOQUINE; NEVIRAPINE; PRIMAQUINE; PROGUANIL; QUININE; RITONAVIR; SULFADOXINE PLUS TRIMETHOPRIM; ZIDOVUDINE;

ANEMIA; BLOOD TRANSFUSION; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG INTERMITTENT THERAPY; EPIDEMIOLOGICAL DATA; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALARIA; MALARIA CONTROL; MIXED INFECTION; PARASITEMIA; PLACENTAL TRANSFER; PREGNANT WOMAN; REVIEW; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; BLOOD; COMPLICATION; HIV INFECTIONS; TRANSMISSION;

CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; MALARIA;

EID: 77952888928     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.10.008     Document Type: Review

References (98)

1. Renia L., Potter S.M. Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol 2006, 28:589-595.
2. Van geertruyden J.P., D'Alessandro U. Malaria and HIV: a silent alliance. Trends Parasitol 2007, 23:465-467.
3. Chandramohan D., Greenwood B.M. Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? Int J Epidemiol 1998, 27:296-301.
4. Korenromp E.L., Williams B.G., de Vlas S.J., Gouws E., Gilks C.F., Ghys P.D., et al. Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis 2005, 11:1410-1419.
5. Burger S., Poles M.A. Natural history and pathogenesis of human immunodeficiency virus infection. Semin Liver Dis 2003, 23:115-124.
6. Schofield L., Grau G.E. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005, 5:722-735.
7. Martin-Blondel G., Barry M., Porte L., Busato F., Massip P., Benoit-Vical F., et al. [Impact of HIV infection on malaria in adults]. Med Mal Infect 2007, 37:629-636.
8. French N., Nakiyingi J., Lugada E., Watera C., Whitworth J.A., Gilks C.F. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. Aids 2001, 15:899-906.
9. Grimwade K., French N., Mbatha D.D., Zungu D.D., Dedicoat M., Gilks C.F. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. Aids 2004, 18:547-554.
10. Bloland P.B., Wirima J.J., Steketee R.W., Chilima B., Hightower A., Breman J.G. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. Aids 1995, 9:721-726.
11. Brabin B.J., Ginny M., Sapau J., Galme K., Paino J. Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea. Ann Trop Med Parasitol 1990, 84:11-24.
12. ter Kuile F.O., Parise M.E., Verhoeff F.H., Udhayakumar V., Newman R.D., van Eijk A.M., et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 2004, 71:41-54.
13. Verhoeff F.H., Brabin B.J., Hart C.A., Chimsuku L., Kazembe P., Broadhead R.L. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 1999, 4:5-12.
14. Kamya M.R., Gasasira A.F., Yeka A., Bakyaita N., Nsobya S.L., Francis D., et al. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 2006, 193:9-15.
15. Shah S.N., Smith E.E., Obonyo C.O., Kain K.C., Bloland P.B., Slutsker L., et al. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya. J Infect Dis 2006, 194:1519-1528.
16. Report on the global AIDS epidemic. 2008. WHO Library Cataloguing-in-publication Data. UNAIDS/08.25E/JC1510E ISBN 978 92 9 173711 6.
17. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
18. World malaria report. 2008. WHO Library Cataloguing-in-publication Data. WHO/HTM/GMP/2008.1. ISBN 978 92 4 156369 7.
19. Sachs J., Malaney P. The economic and social burden of malaria. Nature 2002, 415:680-685.
20. Baudon D., Louis F.J., Martet G. In Africa, urban malaria is the malaria of tomorrow. Med Trop (Mars) 1996, 56:323-325.
21. Dabis F., Ekpini E.R. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002, 359:2097-2104.
22. De Cock K.M., Fowler M.G., Mercier E., de Vincenzi I., Saba J., Hoff E., et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000, 283:1175-1182.
23. Whitworth J., Morgan D., Quigley M., Smith A., Mayanja B., Eotu H., et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000, 356:1051-1056.
24. Goletti D., Weissman D., Jackson R.W., Graham N.M., Vlahov D., Klein R.S., et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996, 157:1271-1278.
25. Bentwich Z., Maartens G., Torten D., Lal A.A., Lal R.B. Concurrent infections and HIV pathogenesis. AIDS 2000, 14:2071-2081.
26. Dyer J.R., Kazembe P., Vernazza P.L., Gilliam B.L., Maida M., Zimba D., et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998, 177:1742-1746.
27. Stevenson M., Stanwick T.L., Dempsey M.P., Lamonica C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990, 9:1551-1560.
28. Poli G., Pantaleo G., Fauci A.S. Immunopathogenesis of human immunodeficiency virus infection. Clin Infect Dis 1993, 17(Suppl 1):S224-229.
29. Lawn S.D., Butera S.T., Folks T.M. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001, 14:753-777. [table of contents].
30. Froebel K., Howard W., Schafer J.R., Howie F., Whitworth J., Kaleebu P., et al. Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults. Parasite Immunol 2004, 26:213-217.
31. Weissman D., Barker T.D., Fauci A.S. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996, 183:687-692.
32. Freitag C., Chougnet C., Schito M., Near K.A., Shearer G.M., Li C., et al. Malaria infection induces virus expression in human immunodeficiency virus transgenic mice by CD4 T cell-dependent immune activation. J Infect Dis 2001, 183:1260-1268.
33. Worku S., Bjorkman A., Troye-Blomberg M., Jemaneh L., Farnert A., Christensson B. Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct gammadelta+ T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol 1997, 108:34-41.
34. Bate C.A., Taverne J., Playfair J.H. Malarial parasites induce TNF production by macrophages. Immunology 1988, 64:227-231.
35. Xiao L., Owen S.M., Rudolph D.L., Lal R.B., Lal A.A. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 1998, 177:437-445.
36. Pisell T.L., Hoffman I.F., Jere C.S., Ballard S.B., Molyneux M.E., Butera S.T., et al. Immune activation and induction of HIV-1 replication within CD14 macrophages during acute Plasmodium falciparum malaria coinfection. Aids 2002, 16:1503-1509.
37. Fievet N., Moussa M., Tami G., Maubert B., Cot M., Deloron P., et al. Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring the Th1-type pathway, in the human placenta. J Infect Dis 2001, 183:1530-1534.
38. Fried M., Muga R.O., Misore A.O., Duffy P.E. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998, 160:2523-2530.
39. Ayouba A., Badaut C., Kfutwah A., Cannou C., Juillerat A., Gangnard S., et al. Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum. AIDS 2008, 22:785-787.
40. Nti B.K., Slingluff J.L., Keller C.C., Hittner J.B., Ong'echa J.M., Murphey-Corb M., et al. Stage-specific effects of Plasmodium falciparum-derived hemozoin on blood mononuclear cell TNF-alpha regulation and viral replication. Aids 2005, 19:1771-1780.
41. Moore J.M., Chaisavaneeyakorn S., Perkins D.J., Othoro C., Otieno J., Nahlen B.L., et al. Hemozoin differentially regulates proinflammatory cytokine production in human immunodeficiency virus-seropositive and -seronegative women with placental malaria. Infect Immun 2004, 72:7022-7029.
42. Kublin J.G., Patnaik P., Jere C.S., Miller W.C., Hoffman I.F., Chimbiya N., et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005, 365:233-240.
43. Tatfeng Y.M., Ihongbe J.C., Okodua M., Oviasogie E., Isibor J., Tchougang S., et al. CD4 count, viral load and parasite density of HIV positive individuals undergoing malaria treatment with dihydroartemisinin in Benin City, Edo state, Nigeria. J Vector Borne Dis 2007, 44:111-115.
44. Hoffman I.F., Jere C.S., Taylor T.E., Munthali P., Dyer J.R., Wirima J.J., et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. Aids 1999, 13:487-494.
45. Brouwer K.C., Mirel L.B., Yang C., Lal R.B., Kolczak M.S., Van Eijk A.M., et al. Subclinical Plasmodium falciparum infection and HIV-1 viral load. Emerg Infect Dis 2007, 13:351-353.
46. Kapiga S.H., Bang H., Spiegelman D., Msamanga G.I., Coley J., Hunter D.J., et al. Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002, 30:316-323.
47. Mwapasa V., Rogerson S.J., Molyneux M.E., Abrams E.T., Kamwendo D.D., Lema V.M., et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. Aids 2004, 18:1051-1059.
48. Mermin J., Lule J.R., Ekwaru J.P. Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 2006, 41:129-130.
49. Whitworth J.A., Hewitt K.A. Effect of malaria on HIV-1 progression and transmission. Lancet 2005, 365:196-197.
50. Wyler D.J. Peripheral lymphocyte subpopulations in human falciparum malaria. Clin Exp Immunol 1976, 23:471-476.
51. Mellors J.W., Munoz A., Giorgi J.V., Margolick J.B., Tassoni C.J., Gupta P., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126:946-954.
52. Anglaret X., Chene G., Attia A., Toure S., Lafont S., Combe P., et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan. Cote d'Ivoire: a randomised trial. Cotrimo-CI study group. Lancet 1999, 353:1463-1468.
53. Mermin J., Lule J., Ekwaru J.P., Malamba S., Downing R., Ransom R., et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004, 364:1428-1434.
54. Van Geertruyden J.P., Mulenga M., Kasongo W., Polman K., Colebunders R., Kestens L., et al. CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr 2006, 43:363-367.
55. Morgan D., Whitworth J. The natural history of HIV-1 infection in Africa. Nat Med 2001, 7:143-145.
56. Quigley M.A., Hewitt K., Mayanja B., Morgan D., Eotu H., Ojwiya A., et al. The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults. Trop Med Int Health 2005, 10:894-900.
57. Kalyesubula I., Musoke-Mudido P., Marum L., Bagenda D., Aceng E., Ndugwa C., et al. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J 1997, 16:876-881.
58. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N Engl J Med 2000, 342:921-929.
59. Pilcher C.D., Tien H.C., Eron J.J., Vernazza P.L., Leu S.Y., Stewart P.W., et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004, 189:1785-1792.
60. Rogier C., Ly A.B., Tall A., Cisse B., Trape J.F. Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Am J Trop Med Hyg 1999, 60:410-420.
61. Abu-Raddad L.J., Patnaik P., Kublin J.G. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006, 314:1603-1606.
62. Naniche D., Lahuerta M., Bardaji A., Sigauque B., Romagosa C., Berenguera A., et al. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria. HIV Med 2008, 9:757-764.
63. Shaffer N., Roongpisuthipong A., Siriwasin W., Chotpitayasunondh T., Chearskul S., Young N.L., et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 1999, 179:590-599.
64. The European collaborative study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999;13:1377-85.
65. Rowe J.A., Kyes S.A. The role of Plasmodium falciparum var genes in malaria in pregnancy. Mol Microbiol 2004, 53:1011-1019.
66. Ordi J., Ismail M.R., Ventura P.J., Kahigwa E., Hirt R., Cardesa A., et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998, 22:1006-1011.
67. Tkachuk A.N., Moormann A.M., Poore J.A., Rochford R.A., Chensue S.W., Mwapasa V., et al. Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. J Infect Dis 2001, 183:967-972.
68. Salvatori F., Scarlatti G. HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res Hum Retroviruses 2001, 17:925-935.
69. Jaworowski A., Kamwendo D.D., Ellery P., Sonza S., Mwapasa V., Tadesse E., et al. CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J Infect Dis 2007, 196:38-42.
70. Abrams E.T., Brown H., Chensue S.W., Turner G.D., Tadesse E., Lema V.M., et al. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J Immunol 2003, 170:2759-2764.
71. Rogerson S.J., Mkundika P., Kanjala M.K. Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology. J Clin Microbiol 2003, 41:1370-1374.
72. Ayouba A., Nerrienet E., Menu E., Lobe M.M., Thonnon J., Leke R.J., et al. Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon. Am J Trop Med Hyg 2003, 69:447-449.
73. Brahmbhatt H., Kigozi G., Wabwire-Mangen F., Serwadda D., Sewankambo N., Lutalo T., et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. Aids 2003, 17:2539-2541.
74. Brahmbhatt H., Sullivan D., Kigozi G., Askin F., Wabwire-Mangenm F., Serwadda D., et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 2008, 47:472-476.
75. Menendez C., Bardaji A., Sigauque B., Romagosa C., Sanz S., Serra-Casas E., et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS ONE 2008, 3:e1934.
76. Ayisi J.G., van Eijk A.M., Newman R.D., ter Kuile F.O., Shi Y.P., Yang C., et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004, 10:643-652.
77. Inion I., Mwanyumba F., Gaillard P., Chohan V., Verhofstede C., Claeys P., et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003, 188:1675-1678.
78. Greenberg A.E., Nguyen-Dinh P., Mann J.M., Kabote N., Colebunders R.L., Francis H., et al. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA 1988, 259:545-549.
79. Moore A., Herrera G., Nyamongo J., Lackritz E., Granade T., Nahlen B., et al. Estimated risk of HIV transmission by blood transfusion in Kenya. The Lancet 2001, 358:657-660.
80. The State of the World's Children. UNICEF. 2009.
81. Gasasira A.F., Dorsey G., Kamya M.R., Havlir D., Kiggundu M., Rosenthal P.J., et al. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol 2006, 44:3021-3024.
82. Ghosh K., Javeri K.N., Mohanty D., Parmar B.D., Surati R.R., Joshi S.H. False-positive serological tests in acute malaria. Br J Biomed Sci 2001, 58:20-23.
83. Khoo S., Back D., Winstanley P. The potential for interactions between antimalarial and antiretroviral drugs. Aids 2005, 19:995-1005.
84. Skinner-Adams T.S., McCarthy J.S., Gardiner D.L., Andrews K.T. HIV and malaria co-infection: interactions and consequences of chemotherapy. Trends Parasitol 2008, 24:264-271.
85. Uneke C.J., Ogbonna A. Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents. Trans R Soc Trop Med Hyg 2008.
86. Parise M.E., Ayisi J.G., Nahlen B.L., Schultz L.J., Roberts J.M., Misore A., et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998, 59:813-822.
87. Filler S.J., Kazembe P., Thigpen M., Macheso A., Parise M.E., Newman R.D., et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006, 194:286-293.
88. Thera M.A., Sehdev P.S., Coulibaly D., Traore K., Garba M.N., Cissoko Y., et al. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 2005, 192:1823-1829.
89. Mermin J., Ekwaru J.P., Liechty C.A., Were W., Downing R., Ransom R., et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006, 367:1256-1261.
90. Whitty C.J., Jaffar S. Plasmodium falciparum cross resistance. Lancet 2002, 359:80.
91. Karp C.L., Auwaerter P.G. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis 2007, 45:1208-1213.
92. Malamba S.S., Mermin J., Reingold A., Lule J.R., Downing R., Ransom R., et al. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg 2006, 75:375-380.
93. Kamya M.R., Gasasira A.F., Achan J., Mebrahtu T., Ruel T., Kekitiinwa A., et al. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS 2007, 21:2059-2066.
94. Czeizel A. A case-control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 1990, 4:305-313.
95. Redmond A.M., Skinner-Adams T., Andrews K.T., Gardiner D.L., Ray J., Kelly M., et al. Antimalarial activity of sera from subjects taking HIV protease inhibitors. Aids 2007, 21:763-765.
96. Nathoo S., Serghides L., Kain K.C. Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. Lancet 2003, 362:1039-1041.
97. Pardridge W.M., Yang J., Diagne A. Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes. Immunol Lett 1998, 64:45-47.
98. Fesen M.R., Kohn K.W., Leteurtre F., Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci U S A 1993, 90:2399-2403.